Preclinical Protocol for Focused Ultrasound-Mediated Nanoparticle Delivery🌐Translate

Pitch

Written by the team. Not an investment offer and not advice.

Problem

A new approach using focused ultrasound, nanoparticles, and microRNAs targets glioblastoma. This project outlines a safe, small-scale protocol for preclinical research teams.

🌐Translate

What they are building

A written protocol (PDF or paper checklist) describing materials, safety checks, nanoparticle preparation, ultrasound settings, and monitoring steps, to be tested by one research team in a controlled lab setting using established animal models. Limit: one lab, max five researchers, duration four weeks. Unvalidated hypothesis; full brief: /blog/scientists-use-sound-waves-to-deliver-a-new-atta-2026-11-02 Source: Link

🌐Translate

Who it is for

Academic or institutional research teams working on glioblastoma or nanoparticle-based therapies, particularly those with access to preclinical models and focused ultrasound equipment.

🌐Translate

Why it matters

Test whether the protocol enables more consistent or targeted delivery of microRNAs to tumor tissue compared to standard nanoparticle injection, as measured by tissue distribution in preclinical models. Proposed validation: Proposed pilot target: At least 80% of attempted deliveries result in detectable microRNA presence in tumor tissue (measured by qPCR or imaging) within four weeks, compared to baseline of standard injection. Measure via lab records and tissue analysis logs.

🌐Translate